<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/103D3F37-4066-444D-93DA-A10CF99F10F5"><gtr:id>103D3F37-4066-444D-93DA-A10CF99F10F5</gtr:id><gtr:name>Austrian Academy of Sciences</gtr:name><gtr:address><gtr:line1>Lazarettgasse 14</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Weatherall Inst of Molecular Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/103D3F37-4066-444D-93DA-A10CF99F10F5"><gtr:id>103D3F37-4066-444D-93DA-A10CF99F10F5</gtr:id><gtr:name>Austrian Academy of Sciences</gtr:name><gtr:address><gtr:line1>Lazarettgasse 14</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/32E7600A-6119-4C42-8BB1-32EE10FCE29D"><gtr:id>32E7600A-6119-4C42-8BB1-32EE10FCE29D</gtr:id><gtr:firstName>Claus</gtr:firstName><gtr:surname>Nerlov</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0900892"><gtr:id>E92316D3-2951-4DB5-822D-F76DCEBF8DE6</gtr:id><gtr:title>Transcriptional regulation of hematopoietic self-renewal, lineage specification and leukemogenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900892</gtr:grantReference><gtr:abstractText>The blood system is necessary for many functions of the body, and also gives rise to several types of cancer. In this project we will try to understand how the many blood cell types are specified from a sibgle stem cell, and how this process is disturbed in leukemias. By using the body?s own molecules to alter the fate of the stem cells we will analyze if leukemia development can be accelerated and delayed by signals normally used to increase the production of white and red blood cells, respectively</gtr:abstractText><gtr:technicalSummary>The purpose of the proposed Programme is to conduct an integrated research projects addressing how intrinsic regulators (transcription factors) and extrinsic cues (cytokines) interact to control the lineage commitment and self-renewal of hematopoietic cells, specifically through modulation of of their lineage priming and gene expression. We will also investigate the role played by these processes in the formation of leukemic stem cells in CEBPA mutant AML. To achieve this we will use conditional genetics to specifically eliminate intrinsic regulators (GATA-1, FOG-1, C/EBPa) and activate cytokine/growth factor receptors (Flt3, GM-CSFR, EpoR), and generate genetically precise models of human AML. The analysis of the hematopoietic system by flow cytometry will be complemented by characterization of the transcriptional changes induced, as well as studeis of the kinetics by which leukemic stem cells arise, and how this is modulated by extrinsic signals.</gtr:technicalSummary><gtr:fund><gtr:end>2016-06-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2754048</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Stem Cell Institute</gtr:department><gtr:description>Hematopoiesis and leukemogenesis</gtr:description><gtr:id>78882903-8130-4E59-9D39-BD78CEE8A7A8</gtr:id><gtr:impact>Mancini E, Sanjuan-Pla A, Luciani L, Moore S, Grover A, Zay A, Rasmussen KD, Luc S, Bilbao D, O'Carroll D, Jacobsen SE, Nerlov C. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors. EMBO J. 2011 Nov 8. doi: 10.1038/emboj.2011.390

Kharazi S, Mead AJ, Mansour A, Hultquist A, B&amp;ouml;iers C, Luc S, Buza-Vidas N, Ma Z, Ferry H, Atkinson D, Reckzeh K, Masson K, Cammenga J, R&amp;ouml;nnstrand L, Arai F, Suda T, Nerlov C, Sitnicka E, Jacobsen SE. Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation. Blood. 2011 Sep 29;118(13):3613-21.

Kaveri D., P. Kastner, D. Demb&amp;eacute;l&amp;eacute;, C. Nerlov, S. Chan and P. Kirstetter. 2013. ?-catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL. Blood 122: 694-704.

Zhang,H., M. Alberich-Jord&amp;agrave;, G. Amabile, H. Yang, P.B. Staber, A. DiRuscio, R.S. Welner, A. Ebralidze, J. Zhang, E. Levantini, V. Lefebvre, P.J.M. Valk, R. Delwel, M. Hoogenkamp, C. Nerlov, J. Cammenga, B. Saez, D.T. Scadden, C. Bonifer, M. Ye and D.G. Tenen. 2013. Sox4 is a key oncogenic target in C/EBPa mutant Acute Myeloid Leukemia. Cancer Cell 24: 575-88.

Grebien, F., M. Vedadi, M. Getlik, R. Giambruno, A. Grover, R. Avellino, A. Skucha, S. Vittori, E. Kuznetsova, D. Smil, D. Barsyte-Lovejoy, F. Li, G. Poda, M. Schapira, H. Wu, A. Dong, G. Senisterra, A. Stukalov, K.V.M. Huber, A. Sch&amp;ouml;negger, M. Bilban, C. Bock, P.J. Brown, J. Zuber, K.L. Bennett, R. Al-awar, R. Delwel, C. Nerlov, C.H. Arrowsmith and G. Superti-Furga. 2015. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPa N-terminal leukemia. Nat. Chem. Biol. 11: 571-8.</gtr:impact><gtr:partnerContribution>Scientific discussion, methodology</gtr:partnerContribution><gtr:piContribution>Genetic modelling of hematopoiesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL School of Life and Medical Sciences</gtr:department><gtr:description>In vivo imaging of platelet formation</gtr:description><gtr:id>FA27A8EF-B417-4CD1-B447-AB306B02C0B6</gtr:id><gtr:impact>Manuscript submitted.</gtr:impact><gtr:partnerContribution>In vivo imaging and cryo-EM analysis</gtr:partnerContribution><gtr:piContribution>We provides fluorescent reporter mice to selectively label megakaryocyte-lineage cells in vivo</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Molecular Haematology Unit</gtr:department><gtr:description>Hematopoiesis and leukemogenesis</gtr:description><gtr:id>82F3090A-4288-4915-8F78-22FC153163F0</gtr:id><gtr:impact>Mancini E, Sanjuan-Pla A, Luciani L, Moore S, Grover A, Zay A, Rasmussen KD, Luc S, Bilbao D, O'Carroll D, Jacobsen SE, Nerlov C. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors. EMBO J. 2011 Nov 8. doi: 10.1038/emboj.2011.390

Kharazi S, Mead AJ, Mansour A, Hultquist A, B&amp;ouml;iers C, Luc S, Buza-Vidas N, Ma Z, Ferry H, Atkinson D, Reckzeh K, Masson K, Cammenga J, R&amp;ouml;nnstrand L, Arai F, Suda T, Nerlov C, Sitnicka E, Jacobsen SE. Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation. Blood. 2011 Sep 29;118(13):3613-21.

Kaveri D., P. Kastner, D. Demb&amp;eacute;l&amp;eacute;, C. Nerlov, S. Chan and P. Kirstetter. 2013. ?-catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL. Blood 122: 694-704.

Zhang,H., M. Alberich-Jord&amp;agrave;, G. Amabile, H. Yang, P.B. Staber, A. DiRuscio, R.S. Welner, A. Ebralidze, J. Zhang, E. Levantini, V. Lefebvre, P.J.M. Valk, R. Delwel, M. Hoogenkamp, C. Nerlov, J. Cammenga, B. Saez, D.T. Scadden, C. Bonifer, M. Ye and D.G. Tenen. 2013. Sox4 is a key oncogenic target in C/EBPa mutant Acute Myeloid Leukemia. Cancer Cell 24: 575-88.

Grebien, F., M. Vedadi, M. Getlik, R. Giambruno, A. Grover, R. Avellino, A. Skucha, S. Vittori, E. Kuznetsova, D. Smil, D. Barsyte-Lovejoy, F. Li, G. Poda, M. Schapira, H. Wu, A. Dong, G. Senisterra, A. Stukalov, K.V.M. Huber, A. Sch&amp;ouml;negger, M. Bilban, C. Bock, P.J. Brown, J. Zuber, K.L. Bennett, R. Al-awar, R. Delwel, C. Nerlov, C.H. Arrowsmith and G. Superti-Furga. 2015. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPa N-terminal leukemia. Nat. Chem. Biol. 11: 571-8.</gtr:impact><gtr:partnerContribution>Scientific discussion, methodology</gtr:partnerContribution><gtr:piContribution>Genetic modelling of hematopoiesis</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Stem Cell Centre Lund</gtr:department><gtr:description>Oncogene collaboration in myeloid leukemogenesis</gtr:description><gtr:id>1474A059-1D47-4DB6-A1CC-2DE63A711655</gtr:id><gtr:impact>Publication:

Reckzeh, K., O. Bereshchenko, A. Mead, M. Rehn, S. Kharazi, S.E. Jacobsen, C. Nerlov* and J. Cammenga*. 2012. Molecular and Cellular Effects of Oncogene Cooperation in a Genetically Accurate AML Mouse Model. Leukemia 26: 1527-36. (* Equal contribution).</gtr:impact><gtr:partnerContribution>Providing an knockin model for FLT3-ITD mutations</gtr:partnerContribution><gtr:piContribution>Generation of an accurate model for CEBPA mutant AML</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Austrian Academy of Sciences</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Research Centre for Molecular Medicine (CeMM)</gtr:department><gtr:description>Hematopoiesis and leukemogenesis</gtr:description><gtr:id>D26BAAB0-5798-46AB-98D2-362E23CC864C</gtr:id><gtr:impact>Mancini E, Sanjuan-Pla A, Luciani L, Moore S, Grover A, Zay A, Rasmussen KD, Luc S, Bilbao D, O'Carroll D, Jacobsen SE, Nerlov C. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors. EMBO J. 2011 Nov 8. doi: 10.1038/emboj.2011.390

Kharazi S, Mead AJ, Mansour A, Hultquist A, B&amp;ouml;iers C, Luc S, Buza-Vidas N, Ma Z, Ferry H, Atkinson D, Reckzeh K, Masson K, Cammenga J, R&amp;ouml;nnstrand L, Arai F, Suda T, Nerlov C, Sitnicka E, Jacobsen SE. Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation. Blood. 2011 Sep 29;118(13):3613-21.

Kaveri D., P. Kastner, D. Demb&amp;eacute;l&amp;eacute;, C. Nerlov, S. Chan and P. Kirstetter. 2013. ?-catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL. Blood 122: 694-704.

Zhang,H., M. Alberich-Jord&amp;agrave;, G. Amabile, H. Yang, P.B. Staber, A. DiRuscio, R.S. Welner, A. Ebralidze, J. Zhang, E. Levantini, V. Lefebvre, P.J.M. Valk, R. Delwel, M. Hoogenkamp, C. Nerlov, J. Cammenga, B. Saez, D.T. Scadden, C. Bonifer, M. Ye and D.G. Tenen. 2013. Sox4 is a key oncogenic target in C/EBPa mutant Acute Myeloid Leukemia. Cancer Cell 24: 575-88.

Grebien, F., M. Vedadi, M. Getlik, R. Giambruno, A. Grover, R. Avellino, A. Skucha, S. Vittori, E. Kuznetsova, D. Smil, D. Barsyte-Lovejoy, F. Li, G. Poda, M. Schapira, H. Wu, A. Dong, G. Senisterra, A. Stukalov, K.V.M. Huber, A. Sch&amp;ouml;negger, M. Bilban, C. Bock, P.J. Brown, J. Zuber, K.L. Bennett, R. Al-awar, R. Delwel, C. Nerlov, C.H. Arrowsmith and G. Superti-Furga. 2015. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPa N-terminal leukemia. Nat. Chem. Biol. 11: 571-8.</gtr:impact><gtr:partnerContribution>Scientific discussion, methodology</gtr:partnerContribution><gtr:piContribution>Genetic modelling of hematopoiesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Physiology &amp; Pharmacology Bristol</gtr:department><gtr:description>In vivo imaging of platelet formation</gtr:description><gtr:id>1B368414-20A6-4E1C-B0CA-D54E6D29B3B0</gtr:id><gtr:impact>Manuscript submitted.</gtr:impact><gtr:partnerContribution>In vivo imaging and cryo-EM analysis</gtr:partnerContribution><gtr:piContribution>We provides fluorescent reporter mice to selectively label megakaryocyte-lineage cells in vivo</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Blog on emergency erythropoiesis</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DC66F1D8-0FF1-4403-AF8B-A7C77E554FB2</gtr:id><gtr:impact>Blog describing a new model for how the body responds to anaemia, based on a publication in Journal of Experimental Medicine, published on the institute web site.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.imm.ox.ac.uk/how-to-make-a-red-blood-cell-and-fast</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog on platelet-biased hematopoietic stem cells.</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B1501119-F38A-425E-9719-C47DCFB8DBFE</gtr:id><gtr:impact>Blog describing the identification of a new stem cell dedicated to preferential and rapid production of platelets (primary research published in Nature)</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.imm.ox.ac.uk/propagating-platelets-a-novel-cancer-therapy</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>138724</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Gordon Piller Studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>The Leukemia &amp; Lymphoma Society</gtr:fundingOrg><gtr:fundingRef>13064</gtr:fundingRef><gtr:id>CC244028-4A49-4F16-983F-7DE2E09671F8</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>212400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR Project Grant</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:fundingRef>11-0724</gtr:fundingRef><gtr:id>00889B0A-E13D-45FC-973F-80CBC7667253</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>233598</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LLR Project Grant</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:fundingRef>13008</gtr:fundingRef><gtr:id>DA6113EB-90FC-40FA-83F8-4DB60BE65838</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>341857</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>E9628A1D-FF85-41F2-9AD7-F31D103118F5</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>175487</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LLR Project Grant</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>5003E80F-F8BC-4144-A161-BDBFA3920537</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Danish Cancer Research Society</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>85DE0D6A-BAAB-405B-840C-50CF6A536E64</gtr:id><gtr:impact>Funding allocation, clinical and basic cancer research</gtr:impact><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Danish Medical Research Council</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A9F91918-1A84-4A9D-B962-84AA39483C37</gtr:id><gtr:impact>Increased funding for academic training of medical doctors, improved recruitment of early stage medicine student to research.</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Using BAC transgenes expressing EGFP at high levels in platelets and erythoid cells we have generated a mouse line where production of cells of all lineages (myeloid, lymphoid, platelet, erythroid) from a stem cell or progenitor population can be monitored</gtr:description><gtr:id>AE0C0915-9396-4213-A7E9-37D544342DBF</gtr:id><gtr:impact>One publication:

Mancini E, Sanjuan-Pla A, Luciani L, Moore S, Grover A, Zay A, Rasmussen KD, Luc S, Bilbao D, O'Carroll D, Jacobsen SE, Nerlov C. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors. EMBO J. 2011 Nov 8. doi: 10.1038/emboj.2011.390</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Complete hematopoietic reporter mouse</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F8CFFF81-FDE8-455A-A777-6A3F6D680FF5"><gtr:id>F8CFFF81-FDE8-455A-A777-6A3F6D680FF5</gtr:id><gtr:title>FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5fb12a98d4056670ebefede87ebda6ba"><gtr:id>5fb12a98d4056670ebefede87ebda6ba</gtr:id><gtr:otherNames>Mead AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2B487D79-7D2F-4B1D-A269-BAA7B2CA11DF"><gtr:id>2B487D79-7D2F-4B1D-A269-BAA7B2CA11DF</gtr:id><gtr:title>Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b63a208352b53e745b735dad97dff01"><gtr:id>8b63a208352b53e745b735dad97dff01</gtr:id><gtr:otherNames>Pietras EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4F418581-7DB3-427A-A6DF-A2343A09F3AB"><gtr:id>4F418581-7DB3-427A-A6DF-A2343A09F3AB</gtr:id><gtr:title>Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b7672660229cf45e66d3c92b9dffa844"><gtr:id>b7672660229cf45e66d3c92b9dffa844</gtr:id><gtr:otherNames>Hoppe PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68A0EE5E-6ECD-439D-A547-92F14516BBBC"><gtr:id>68A0EE5E-6ECD-439D-A547-92F14516BBBC</gtr:id><gtr:title>Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitors.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6bc2a33653d404809acfd047a1a3aa3c"><gtr:id>6bc2a33653d404809acfd047a1a3aa3c</gtr:id><gtr:otherNames>Luis TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/88632650-1AB3-449B-A823-B386B6F42834"><gtr:id>88632650-1AB3-449B-A823-B386B6F42834</gtr:id><gtr:title>Disease evolution and outcomes in familial AML with germline CEBPA mutations.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/89403228fb27ee0dc38ba211144ea08f"><gtr:id>89403228fb27ee0dc38ba211144ea08f</gtr:id><gtr:otherNames>Tawana K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FC502336-CD1A-4E99-A1A2-F73E91503C01"><gtr:id>FC502336-CD1A-4E99-A1A2-F73E91503C01</gtr:id><gtr:title>Dicer is selectively important for the earliest stages of erythroid development.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/867a455fe097c2dfa583641b7668df6a"><gtr:id>867a455fe097c2dfa583641b7668df6a</gtr:id><gtr:otherNames>Buza-Vidas N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B619728A-E183-4F49-8956-B65D75D80388"><gtr:id>B619728A-E183-4F49-8956-B65D75D80388</gtr:id><gtr:title>Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5c898c712828706075492c628cb10fce"><gtr:id>5c898c712828706075492c628cb10fce</gtr:id><gtr:otherNames>Drissen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1401989D-CB3C-4794-8E36-3018BBD4CA2E"><gtr:id>1401989D-CB3C-4794-8E36-3018BBD4CA2E</gtr:id><gtr:title>Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/884a8401cd72205f42779a840d6a93a3"><gtr:id>884a8401cd72205f42779a840d6a93a3</gtr:id><gtr:otherNames>Grover A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A504AE6-A5A4-40AF-8F8A-DBD668B51C26"><gtr:id>3A504AE6-A5A4-40AF-8F8A-DBD668B51C26</gtr:id><gtr:title>Single-cell RNA sequencing reveals molecular and functional platelet bias of aged haematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/884a8401cd72205f42779a840d6a93a3"><gtr:id>884a8401cd72205f42779a840d6a93a3</gtr:id><gtr:otherNames>Grover A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B25829DD-47B8-4535-A008-8D2DE2B689E4"><gtr:id>B25829DD-47B8-4535-A008-8D2DE2B689E4</gtr:id><gtr:title>Pharmacological targeting of the Wdr5-MLL interaction in C/EBPa N-terminal leukemia.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/93aef8b7ba6f133aafd9c389794ee3b5"><gtr:id>93aef8b7ba6f133aafd9c389794ee3b5</gtr:id><gtr:otherNames>Grebien F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3EEF8683-0DBC-4D49-9D2D-2C848929912B"><gtr:id>3EEF8683-0DBC-4D49-9D2D-2C848929912B</gtr:id><gtr:title>FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1d76277cd7538daf1b6bdf3aee812312"><gtr:id>1d76277cd7538daf1b6bdf3aee812312</gtr:id><gtr:otherNames>Mancini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5B12CC45-32C5-4A31-AC5F-A1D63A9D89CE"><gtr:id>5B12CC45-32C5-4A31-AC5F-A1D63A9D89CE</gtr:id><gtr:title>A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5e241df9506cc57c225f4d67f9f5101c"><gtr:id>5e241df9506cc57c225f4d67f9f5101c</gtr:id><gtr:otherNames>Buono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B1E2068-A078-4830-9948-80C8E9EBD025"><gtr:id>7B1E2068-A078-4830-9948-80C8E9EBD025</gtr:id><gtr:title>Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c678f61d9baba78039fd689d1985a666"><gtr:id>c678f61d9baba78039fd689d1985a666</gtr:id><gtr:otherNames>Woll PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2AF642D2-F749-485B-88D3-B4FDD2A762A0"><gtr:id>2AF642D2-F749-485B-88D3-B4FDD2A762A0</gtr:id><gtr:title>Pontin is essential for murine hematopoietic stem cell survival.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87cd1e2035ae76105e5e9a85d40b112b"><gtr:id>87cd1e2035ae76105e5e9a85d40b112b</gtr:id><gtr:otherNames>Bereshchenko O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/61F6FC66-4E83-413F-8C38-CBB6BC099E75"><gtr:id>61F6FC66-4E83-413F-8C38-CBB6BC099E75</gtr:id><gtr:title>Erratum: Pharmacological targeting of the Wdr5-MLL interaction in C/EBPa N-terminal leukemia.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/93aef8b7ba6f133aafd9c389794ee3b5"><gtr:id>93aef8b7ba6f133aafd9c389794ee3b5</gtr:id><gtr:otherNames>Grebien F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/35F07FCF-2297-4D01-A617-6670D0568526"><gtr:id>35F07FCF-2297-4D01-A617-6670D0568526</gtr:id><gtr:title>Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/85b238b999083dddfa46c534b0bd1c9a"><gtr:id>85b238b999083dddfa46c534b0bd1c9a</gtr:id><gtr:otherNames>Reckzeh K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/77FCA4CE-248B-4BA7-9ECF-C7A7F3E85881"><gtr:id>77FCA4CE-248B-4BA7-9ECF-C7A7F3E85881</gtr:id><gtr:title>Transcriptional and translational control of C/EBPs: the case for &amp;quot;deep&amp;quot; genetics to understand physiological function.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b6938a5f2b66773222e42e3923ead304"><gtr:id>b6938a5f2b66773222e42e3923ead304</gtr:id><gtr:otherNames>Nerlov C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/07D74F4D-B067-4D35-B911-22F868322F40"><gtr:id>07D74F4D-B067-4D35-B911-22F868322F40</gtr:id><gtr:title>Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87cd1e2035ae76105e5e9a85d40b112b"><gtr:id>87cd1e2035ae76105e5e9a85d40b112b</gtr:id><gtr:otherNames>Bereshchenko O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A360C27A-9F39-44EE-8FA2-00786CA9E917"><gtr:id>A360C27A-9F39-44EE-8FA2-00786CA9E917</gtr:id><gtr:title>Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f40f4f583726e10dea43821160160bc"><gtr:id>3f40f4f583726e10dea43821160160bc</gtr:id><gtr:otherNames>Kharazi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0D003D0C-3F5F-4E5C-AD3A-46974EB07D5E"><gtr:id>0D003D0C-3F5F-4E5C-AD3A-46974EB07D5E</gtr:id><gtr:title>Hematopoietic Lineage Diversification, Simplified.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5c898c712828706075492c628cb10fce"><gtr:id>5c898c712828706075492c628cb10fce</gtr:id><gtr:otherNames>Drissen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BDBCAC59-C637-4235-B269-9A2F444A2430"><gtr:id>BDBCAC59-C637-4235-B269-9A2F444A2430</gtr:id><gtr:title>Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9dcbcbb174ef85060f893c5185d2dbd0"><gtr:id>9dcbcbb174ef85060f893c5185d2dbd0</gtr:id><gtr:otherNames>Sanjuan-Pla A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92C4924B-2A6D-48F3-99A5-03CBB260C252"><gtr:id>92C4924B-2A6D-48F3-99A5-03CBB260C252</gtr:id><gtr:title>Sox4 is a key oncogenic target in C/EBPa mutant acute myeloid leukemia.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1bde23452702f3d087e5f35cb87dd0e1"><gtr:id>1bde23452702f3d087e5f35cb87dd0e1</gtr:id><gtr:otherNames>Zhang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900892</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>